Non-active Site Changes Elicit Broad-based Cross-resistance of the HIV-1 Protease to Inhibitors
Open Access
- 1 August 1999
- journal article
- Published by Elsevier BV
- Vol. 274 (34), 23699-23701
- https://doi.org/10.1074/jbc.274.34.23699
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Resistance to Human Immunodeficiency Virus Type 1 Protease InhibitorsAntimicrobial Agents and Chemotherapy, 1998
- HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapyAIDS, 1998
- Virological and clinical implications of resistance to HIV-1 protease inhibitors.Drug Resistance Updates, 1998
- Molecular Basis of HIV-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed with Cyclic Urea InhibitorsBiochemistry, 1997
- Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical TrialsJournal of Biological Chemistry, 1996
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant VariantsPublished by Elsevier BV ,1996
- Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)AIDS, 1996
- Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical TrialsPublished by Elsevier BV ,1995
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985